Brokerages Set Teladoc Health, Inc. (NYSE:TDOC) PT at $11.26

Shares of Teladoc Health, Inc. (NYSE:TDOC) have received a consensus rating of “Hold” from the eighteen research firms that are presently covering the company, MarketBeat.com reports. Eleven analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12 month price target among analysts that have covered the stock in the last year is $11.26.

TDOC has been the subject of several research reports. Needham & Company LLC restated a “hold” rating on shares of Teladoc Health in a research report on Thursday, February 27th. Royal Bank of Canada raised their price objective on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Oppenheimer cut their price objective on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research report on Friday, January 24th. The Goldman Sachs Group cut their price target on Teladoc Health from $16.00 to $13.00 and set a “buy” rating for the company in a research note on Monday, March 3rd. Finally, Piper Sandler cut their price target on Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a research note on Thursday, February 27th.

Teladoc Health Trading Down 3.8 %

Teladoc Health stock opened at $8.17 on Tuesday. Teladoc Health has a 52 week low of $6.76 and a 52 week high of $15.68. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The stock has a market capitalization of $1.42 billion, a P/E ratio of -1.42 and a beta of 1.27. The stock has a 50-day simple moving average of $10.45 and a 200 day simple moving average of $9.72.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The company had revenue of $640.49 million for the quarter, compared to analyst estimates of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. Analysts expect that Teladoc Health will post -1.16 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of TDOC. Versant Capital Management Inc increased its holdings in shares of Teladoc Health by 313.8% during the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock worth $29,000 after buying an additional 2,441 shares in the last quarter. Whipplewood Advisors LLC acquired a new position in shares of Teladoc Health during the fourth quarter worth $29,000. Lindbrook Capital LLC increased its holdings in shares of Teladoc Health by 78.9% during the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider’s stock worth $33,000 after buying an additional 1,612 shares in the last quarter. Sterling Capital Management LLC increased its holdings in shares of Teladoc Health by 776.7% during the fourth quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider’s stock worth $42,000 after buying an additional 4,101 shares in the last quarter. Finally, Pilgrim Partners Asia Pte Ltd acquired a new position in shares of Teladoc Health during the fourth quarter worth $60,000. 76.82% of the stock is currently owned by institutional investors and hedge funds.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.